Holen Sie sich die Stockscreener-App
40.60
1.26%
-0.52
Handel nachbörslich:
40.60
Qiagen Nv Aktie (QGEN) Neueste Nachrichten
BlackRock Reports 10.6% Capital and 11.8% Voting Stake in Qiagen - TipRanks
Release according to Article 40, Section 1 of the WpHG - TradingView
Today's Analyst Upgrade: Deutsche Bank Recommends Buy for QGEN | QGEN Stock News - GuruFocus
Korea Investment CORP Sells 93,167 Shares of Qiagen N.V. $QGEN - MarketBeat
Deutsche Bank upgrades Qiagen stock rating to buy on valuation - Investing.com
QIAGEN NV : Upgraded to Buy by Deutsche Bank - marketscreener.com
Deutsche Bank Upgrades Qiagen NV (QGEN) to Buy - StreetInsider
Assessing Qiagen (QGEN) Valuation After Recent Share Price Weakness - Yahoo Finance
BlackRock Builds Significant Stake in Qiagen with Over 11% of Voting Rights - TipRanks
PTA-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG - TradingView
Qiagen (NYSE:QGEN) Downgraded by Zacks Research to Strong Sell - MarketBeat
Jefferies Financial Group Inc. Makes New Investment in Qiagen N.V. $QGEN - MarketBeat
QIAGEN Receives U.S. Clearance for Gastrointestinal Panels on Fully Automated QIAstat-Dx Rise Syndro - pharmiweb.com
Why is Qiagen (QGEN) down 9.4% since last earnings report? - MSN
Natixis Advisors LLC Increases Stock Position in Qiagen N.V. $QGEN - MarketBeat
Qiagen N.V. (NYSE:QGEN) Given Average Recommendation of "Hold" by Analysts - MarketBeat
Molecular Diagnostics Market Outlook: Set to Grow at 10%+ CAGR Through 2031 as Precision Medicine and Genetic Testing Advance, Says Mordor Intelligence - GlobeNewswire Inc.
Qiagen N.V. $QGEN Shares Acquired by Barclays PLC - MarketBeat
Qiagen at Leerink Global Healthcare Conference: Strategic Growth and Challenges - Investing.com India
CEO Change: Is Qiagen NV exposed to political risk2025 Growth vs Value & Consistent Profit Trade Alerts - baoquankhu1.vn
Why Is Qiagen (QGEN) Down 9.4% Since Last Earnings Report? - Yahoo Finance
Victory Capital Management Inc. Decreases Stock Position in Qiagen N.V. $QGEN - MarketBeat
Did Qiagen’s Strategic Review Signal A Sale, Or Just A SHIFT Toward Capital Returns? - Smartkarma
Segall Bryant & Hamill LLC Lowers Position in Qiagen N.V. $QGEN - MarketBeat
Qiagen Reports Higher Stake by Massachusetts Financial Services in Voting Rights Disclosure - The Globe and Mail
Qiagen Reports Restricted Stock Unit Grant to Supervisory Board Member - The Globe and Mail
Qiagen discloses RSU vesting and share settlement for board member Eva Pisa - The Globe and Mail
QIAGEN Updates Total Voting Rights to 206.8 Million - TipRanks
PTA-NVR: QIAGEN N.V.: Total Voting Rights Announcement according to Article 41 of the WpHG - TradingView
Total Voting Rights Announcement according to Article 41 of the WpHG - TradingView
Qiagen N.V. (NYSE:QGEN) Sees Significant Growth in Short Interest - MarketBeat
BlackRock Lifts Stake in Qiagen to Over 10% of Capital - TipRanks
Qiagen Discloses Executive Equity Award Vesting Under Long-Term Incentive Plan - TipRanks
Qiagen Reports Grant of Restricted Stock Units to Board Member - TipRanks
Qiagen Grants Performance Stock Units to Managing Board Member - TipRanks
QIAGEN Reports Supervisory Board Member’s Restricted Stock Unit Release - TipRanks
Qiagen Discloses Manager’s Restricted Stock Unit Vesting and Share Settlement - TipRanks
QIAGEN reports executive equity award vesting under MAR disclosure rules - TipRanks
PTA-DD: QIAGEN N.V.: Managers' transactions announcement according to article 19 MAR - TradingView
Managers' transactions announcement according to article 19 MAR - TradingView
Qiagen (QGEN) Shares Cross Below 200 DMA - Nasdaq
BlackRock Discloses 10.68% Capital Interest and 11.8% Voting Stake in Qiagen - TipRanks
Qiagen N.V. (QGEN) Presents at Morgan Stanley European Healthcare ConferenceSlideshow - Seeking Alpha
Intech Investment Management LLC Invests $3.27 Million in Qiagen N.V. $QGEN - MarketBeat
Qiagen CEO says working with advisers on strategic review (QGEN:NYSE) - Seeking Alpha
Qiagen NV (QGEN) Trading Down 3.11% on Mar 2 - GuruFocus
QIAGEN engages advisors to review strategic alternatives - StreetInsider
getLinesFromResByArray error: size == 0 How Qiagen N.V. stock performs in rate cut cyclesJuly 2025 Outlook & Safe Entry Point Identification - mfd.ru
Qiagen N.V. (QGEN) Stock Report: Potential 10.91% Upside With Strong Buy Ratings - DirectorsTalk Interviews
Zacks Research Comments on Qiagen's Q4 Earnings (NYSE:QGEN) - MarketBeat
JPMorgan Chase & Co. Sells 512,299 Shares of Qiagen N.V. $QGEN - MarketBeat
QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG - Pressetext
Surge in Options Trading Volume for nLight and Qiagen - Intellectia AI
DWS Investment Discloses 2.76% Voting Stake in Qiagen - TipRanks
Is Qiagen N.V. in a long term uptrendRate Hike & Daily Market Momentum Tracking - mfd.ru
Vanguard Group Inc. Raises Holdings in Qiagen N.V. $QGEN - MarketBeat
Zacks Research Issues Negative Outlook for Qiagen Earnings - MarketBeat
Total non-current assets of QIAGEN NV – XETR:QIA - TradingView
BlackRock Builds 11% Stake and 12% Voting Power in Qiagen - TipRanks
Traders Purchase Large Volume of Call Options on Qiagen (NYSE:QGEN) - MarketBeat
0.34%
0.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):